Repository: UIHistories Project: Board of Trustees Minutes - 1984 [PAGE 437]

EXTRACTED TEXT FROM PAGE:

428

BOARD OF TRUSTEES

[November 17

University Patents, Inc., has reported that it does not elect to subject this disclosure to the terms of the services agreement because of a lack of novelty to sup. port patenting and licensing efforts. Subsequent evaluations by University administrators support this finding. T h e University Patent Committee recommends that the University elect not to retain title to this invention and release its rights to the sponsor, the National Science Foundation. 2. Flourescin Mono-P-Guanidinobenzoate Hydrochloride and Flourescin DI-pGuanidinobenzoate Dihydrochloride— Walter F. Mangel, visiting assistant professor of biochemistry, L. Lee Melhado, research associate in chemistry, and Steven P. Leytus, formerly research assistant in biochemistry, Urbana-Champaign, inventors; developed under the sponsorship of the National Institutes of Health. University Patents, Inc., has reported that it does not elect to subject this disclosure to the terms of the servicing agreement. U P I is of the opinion that this invention would support limited patent claims; however, it does not believe that the potential applications are commercially feasible to support the costs of a patenting and licensing effort. The University Patent Committee has recommended that the University elect not to retain title to this invention and release its rights to the sponsor, the National Institutes of Health. 3. Tinea Versicolor Phizz Lotion — Lawrence M. Solomon, professor of dermatology, College of Medicine at Chicago, Gwen Daniels, pharmacy technician, Hospital Pharmacy, Lisa A. Robinson, pharmacist practitioner, Hospital Pharmacy, Frederick P. Siegel, professor of pharmaceutics, College of Pharmacy, and Dennis P. West, clinical assistant professor of dermatology, College of Medicine at Chicago, and associate professor of pharmacy practice, College of Pharmacy, Chicago, inventors. University Patents, Inc., has reported that it does not elect to subject this disclosure to the terms of the servicing agreement. U P I has expressed the opinion that patent protection sufficiently broad to sustain a successful licensing program for the product may not be obtainable. There is the probability as well that expenses incurred in obtaining U.S. Food and Drug Administration approval for the project would be prohibitive. The University Patent Committee has recommended that the University release its rights to the inventors. 4. Greaseless Hair Grooming Aid — Lawrence M. Solomon, professor of dermatology, College of Medicine at Chicago, Gwen Daniels, pharmacy technician, Hospital Pharmacy, Lisa A. Robinson, pharmacist practitioner, Hospital Pharmacy, Frederick P. Siegel, professor of pharmaceutics, College of Pharmacy, and Dennis P. West, clinical assistant professor of dermatology, College of Medicine at Chicago, and associate professor of pharmacy practice, College of Pharmacy, Chicago, inventors. University Patents, Inc., has reported that it does not elect to subject this disclosure to the terms of the servicing agreement. Upon evaluation of the technology, U P I concluded that this invention would not sustain a successful licensing program and, hence, patent protection is not appropriate. The University Patent Committee has recommended that the University release its rights to the inventors. 5. Non-Acnegenic Facial Moisturizer — Lawrence M. Solomon, professor of dermatology, College of Medicine at Chicago, Gwen Daniels, pharmacy technician, Hospital Pharmacy, Lisa A. Robinson, pharmacist practitioner, Hospital Pharmacy, Frederick P. Siegel, professor of pharmaceutics, College of Pharmacy, and Dennis P. West, clinical assistant professor of dermatology, College of Medicine at Chicago, and associate professor of pharmacy practice, College of Pharmacy, Chicago, inventors. University Patents, Inc., has reported that it does not elect to subject this disclosure to the terms of the servicing agreement. Upon evaluation of the tech-